[HTML][HTML] Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A …
JJ Szymanski, RT Sundby, PA Jones, D Srihari… - PLoS …, 2021 - journals.plos.org
Background The leading cause of mortality for patients with the neurofibromatosis type 1 (NF1)
cancer predisposition syndrome is the development of malignant peripheral nerve sheath …
cancer predisposition syndrome is the development of malignant peripheral nerve sheath …
Preferentially expressed antigen in melanoma (PRAME) expression in malignant, but not benign, peripheral nerve sheath tumors
…, GE Yuksek, AC Hirbe, D Srihari… - … of Neuropathology & …, 2021 - academic.oup.com
To the Editor: Preferentially expressed antigen in melanoma (PRAME) is a cancer-testis
antigen that is minimally expressed in adult human tissues other than gonads but is present in …
antigen that is minimally expressed in adult human tissues other than gonads but is present in …
INNV-04. A MULTI-INSTITUTIONAL CLINICAL AND MRI REPOSITORY OF NEUROFIBROMATOSIS TYPE 1-ASSOCIATED PERIPHERAL NERVE SHEATH TUMORS
…, O Michaels, D Kwon, D Borcherding, D Srihari… - Neuro …, 2021 - academic.oup.com
BACKGROUND Individuals with neurofibromatosis type 1 (NF1) frequently have peripheral
nerve sheath tumors (PNST), including plexiform neurofibromas (PNF), atypical …
nerve sheath tumors (PNST), including plexiform neurofibromas (PNF), atypical …
NIMG-16. COMPARISON OF A STIR-AND T1-WEIGHTED-BASED RADIOMICS MODEL TO DIFFERENTIATE BETWEEN PLEXIFORM NEUROFIBROMAS AND …
…, K Pollard, C Pratilas, J Salamon, D Srihari… - Neuro …, 2022 - academic.oup.com
Malignant peripheral nerve sheath tumors (MPNSTs) are the most common cause of death
in patients with neurofibromatosis type 1 (NF-1) yet non-invasive diagnosis and risk …
in patients with neurofibromatosis type 1 (NF-1) yet non-invasive diagnosis and risk …
Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics
…, A Pan, PA Jones, SZ Mahmood, OH Reid, D Srihari… - medRxiv, 2024 - medrxiv.org
Early detection of neurofibromatosis type 1 (NF1) associated peripheral nerve sheath tumors
(PNST) informs clinical decision-making, potentially averting deadly outcomes. Here, we …
(PNST) informs clinical decision-making, potentially averting deadly outcomes. Here, we …
Predictive simulation of leachate transport in a coastal lateritic aquifer when remediated with reactive barrier of nano iron
A Divya, S Shrihari, H Ramesh - Groundwater for sustainable development, 2020 - Elsevier
The current study focuses on determination of extent of groundwater contamination on a typical
tropical coastal aquifer due to a landfill located at Vamnjoor in Dakshina Kannada district…
tropical coastal aquifer due to a landfill located at Vamnjoor in Dakshina Kannada district…
[PDF][PDF] Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1
…, B Prudner, T Ball, Y Wang, D Srihari… - Neuro-oncology …, 2020 - academic.oup.com
Background Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft tissue
sarcomas with high metastatic rates and poor overall patient survival. There are currently no …
sarcomas with high metastatic rates and poor overall patient survival. There are currently no …
Comparison of a STIR-and T1-based radiomics model to differentiate between plexiform neurofibromas and malignant peripheral nerve sheath tumors in …
…, Z Mulder, K Pollard, C Pratilas, J Salamon, D Srihari… - 2023 - AAN Enterprises
Objective: Evaluate the performance of radiomics to classify plexiform neurofibromas (PNF)
and malignant peripheral nerve sheath tumors (MPNST) in NF1 Background: MPNST are the …
and malignant peripheral nerve sheath tumors (MPNST) in NF1 Background: MPNST are the …
NIMG-08. A MULTI-CENTER RADIOMICS-BASED MODEL TO DIFFERENTIATE BETWEEN NEUROFIBROMATOSIS TYPE 1-ASSOCIATED PLEXIFORM …
…, A Hirbe, D Borcherding, D Srihari… - Neuro …, 2021 - academic.oup.com
In recent years, several automatic methods have been proposed to differentiate between
brain tumor recurrence and treatment-related changes following radiotherapy, based on …
brain tumor recurrence and treatment-related changes following radiotherapy, based on …
Abstract B006: Development of a NF1-MPNST-PDX liquid biopsy model using whole-genome sequencing and quantitative PCR of mouse-derived cell-free DNA
…, PK Harris, T Sundby, JJ Szymanski, D Srihari… - Clinical Cancer …, 2022 - AACR
Background: Malignant Peripheral Nerve Sheath Tumors (MPNST) are aggressive, NF1-associated
soft tissue sarcomas with a dismal 40% 5-year survival rate, high rates of disease …
soft tissue sarcomas with a dismal 40% 5-year survival rate, high rates of disease …